Skip to main content
NCBI home page
The Journal of Physiology logoLink to The Journal of Physiology
. 1990 Apr;423:475–484. doi: 10.1113/jphysiol.1990.sp018034

Vasoactive intestinal peptide stimulation of human renal adenylate cyclase in vitro.

B G Charlton 1, D E Neal 1, N L Simmons 1
PMCID: PMC1189769  PMID: 2167366

Abstract

1. A direct action of vasoactive intestinal peptide (VIP) upon human kidney was sought by measurement of renal adenylate cyclase in tissue homogenates and plasma membranes isolated from tissue samples excised for therapeutic reasons. 2. VIP (1 microM) produced a mean stimulation of adenylate cyclase activity of 3.5-fold compared to basal values in cortical plasma membranes; comparative stimulations of 2.8-fold and 27.3-fold were obtained with 1 microM-glucagon and 1 microM-h(1-34) parathyroid hormone respectively. 3. Half-maximal stimulation of human renal cortical plasma membrane adenylate cyclase was observed with a mean value of 35 nM-VIP. 4. The stimulation of renal adenylate cyclase by VIP appeared to be specific because stimulation by glucagon was additive to that obtained with VIP, and the VIP receptor antagonist (4 Cl-D-Phe6, Leu17)-VIP inhibited the VIP-dependent stimulation of adenylate cyclase activity.

Full text

PDF
475

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barajas L., Sokolski K. N., Lechago J. Vasoactive intestinal polypeptide-immunoreactive nerves in the kidney. Neurosci Lett. 1983 Dec 30;43(2-3):263–269. doi: 10.1016/0304-3940(83)90199-4. [DOI] [PubMed] [Google Scholar]
  2. Bodanszky M., Klausner Y. S., Said S. I. Biological activities of synthetic peptides corresponding to fragments of and to the entire sequence of the vasoactive intestinal peptide. Proc Natl Acad Sci U S A. 1973 Feb;70(2):382–384. doi: 10.1073/pnas.70.2.382. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bryant M. G., Polak M. M., Modlin I., Bloom S. R., Albuquerque R. H., Pearse A. G. Possible dual role for vasoactive intestinal peptide as gastrointestinal hormone and neurotransmitter substance. Lancet. 1976 May 8;1(7967):991–993. doi: 10.1016/s0140-6736(76)91863-8. [DOI] [PubMed] [Google Scholar]
  4. Calam J., Dimaline R., Peart W. S., Singh J., Unwin R. J. Effects of vasoactive intestinal polypeptide on renal function in man. J Physiol. 1983 Dec;345:469–475. doi: 10.1113/jphysiol.1983.sp014989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Chabardès D., Gagnan-Brunette M., Imbert-Teboul M., Gontcharevskaia O., Montégut M., Clique A., Morel F. Adenylate cyclase responsiveness to hormones in various portions of the human nephron. J Clin Invest. 1980 Feb;65(2):439–448. doi: 10.1172/JCI109687. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. DeLean A., Munson P. J., Rodbard D. Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves. Am J Physiol. 1978 Aug;235(2):E97–102. doi: 10.1152/ajpendo.1978.235.2.E97. [DOI] [PubMed] [Google Scholar]
  7. Dharmsathaphorn K., Harms V., Yamashiro D. J., Hughes R. J., Binder H. J., Wright E. M. Preferential binding of vasoactive intestinal polypeptide to basolateral membrane of rat and rabbit enterocytes. J Clin Invest. 1983 Jan;71(1):27–35. doi: 10.1172/JCI110748. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Dimaline R., Peart W. S., Unwin R. J. Effects of vasoactive intestinal polypeptide (VIP) on renal function and plasma renin activity in the conscious rabbit. J Physiol. 1983 Nov;344:379–388. doi: 10.1113/jphysiol.1983.sp014946. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Duggan K. A., Macdonald G. J. Vasoactive intestinal peptide: a direct renal natriuretic substance. Clin Sci (Lond) 1987 Feb;72(2):195–200. doi: 10.1042/cs0720195. [DOI] [PubMed] [Google Scholar]
  10. Griffiths N. M., Chabardès D., Imbert-Teboul M., Siaume-Perez S., Morel F., Simmons N. L. Distribution of vasoactive intestinal peptide-sensitive adenylate cyclase activity along the rabbit nephron. Pflugers Arch. 1988 Sep;412(4):363–368. doi: 10.1007/BF01907553. [DOI] [PubMed] [Google Scholar]
  11. Griffiths N. M., Rugg E. L., Simmons N. L. Vasoactive intestinal peptide control of renal adenylate cyclase: in vitro studies of canine renal membranes and cultured canine renal epithelial (MDCK) cells. Q J Exp Physiol. 1989 May;74(3):339–353. doi: 10.1113/expphysiol.1989.sp003276. [DOI] [PubMed] [Google Scholar]
  12. Griffiths N. M., Simmons N. L., Rivier J. Vasoactive intestinal peptide stimulation of renal adenylate cyclase and antagonism by (4Cl-D-Phe6Leu17)VIP. Pflugers Arch. 1989 Jun;414(2):222–227. doi: 10.1007/BF00580967. [DOI] [PubMed] [Google Scholar]
  13. Griffiths N. M., Simmons N. L. Vasoactive intestinal polypeptide regulation of rabbit renal adenylate cyclase activity in vitro. J Physiol. 1987 Jun;387:1–17. doi: 10.1113/jphysiol.1987.sp016558. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Kim J. K., Frohnert P. P., Hui Y. S., Barnes L. D., Farrow G. M., Dousa T. P. Enzymes of cyclic 3',5'-nucleotide metabolism in human renal cortex and renal adenocarcinoma. Kidney Int. 1977 Sep;12(3):172–183. doi: 10.1038/ki.1977.98. [DOI] [PubMed] [Google Scholar]
  15. Knight D. S., Beal J. A., Yuan Z. P., Fournet T. S. Vasoactive intestinal peptide-immunoreactive nerves in the rat kidney. Anat Rec. 1987 Oct;219(2):193–203. doi: 10.1002/ar.1092190213. [DOI] [PubMed] [Google Scholar]
  16. Magistretti P. J., Hof P. R., Martin J. L., Dietl M., Palacios J. M. High- and low-affinity binding sites for vasoactive intestinal peptide (VIP) in the rat kidney revealed by light microscopic autoradiography. Regul Pept. 1988 Nov;23(2):145–152. doi: 10.1016/0167-0115(88)90022-5. [DOI] [PubMed] [Google Scholar]
  17. Mulvehill J. B., Hui Y. S., Barnes L. D., Palumbo P. J., Dousa T. P. Glucagon-sensitive adenylate cyclase in human renal medulla. J Clin Endocrinol Metab. 1976 Feb;42(2):380–384. doi: 10.1210/jcem-42-2-380. [DOI] [PubMed] [Google Scholar]
  18. Pandol S. J., Dharmsathaphorn K., Schoeffield M. S., Vale W., Rivier J. Vasoactive intestinal peptide receptor antagonist [4Cl-D-Phe6, Leu17] VIP. Am J Physiol. 1986 Apr;250(4 Pt 1):G553–G557. doi: 10.1152/ajpgi.1986.250.4.G553. [DOI] [PubMed] [Google Scholar]
  19. Porter J. P., Thrasher T. N., Said S. I., Ganong W. F. Vasoactive intestinal peptide in the regulation of renin secretion. Am J Physiol. 1985 Jul;249(1 Pt 2):F84–F89. doi: 10.1152/ajprenal.1985.249.1.F84. [DOI] [PubMed] [Google Scholar]
  20. Reinecke M., Forssmann W. G. Neuropeptide (neuropeptide Y, neurotensin, vasoactive intestinal polypeptide, substance P, calcitonin gene-related peptide, somatostatin) immunohistochemistry and ultrastructure of renal nerves. Histochemistry. 1988;89(1):1–9. doi: 10.1007/BF00496578. [DOI] [PubMed] [Google Scholar]
  21. Said S. I., Mutt V. Polypeptide with broad biological activity: isolation from small intestine. Science. 1970 Sep 18;169(3951):1217–1218. doi: 10.1126/science.169.3951.1217. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Physiology are provided here courtesy of The Physiological Society

RESOURCES